American Journal of Obstetrics & Gynecology
Volume 203, Issue 1 , Pages 52.e1-52.e6, July 2010

Maternal use of bupropion and risk for congenital heart defects

Presented at the 49th Annual Meeting of the Teratology Society in Rio Grande, Puerto Rico, June 27-July 1, 2009, and at the 25th International Conference of Pharmacoepidemiology and Therapeutic Risk Management in Providence, Rhode Island, August 16-19, 2009.

  • Sura Alwan, MSc

      Affiliations

    • Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada
    • ,
  • Jennita Reefhuis, PhD

      Affiliations

    • National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA
    • Corresponding Author InformationReprints: Jennita Reefhuis, PhD, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, 1600 Clifton Rd., MS E-86, Atlanta, GA 30333
    • ,
  • Lorenzo D. Botto, MD

      Affiliations

    • Division of Medical Genetics, Department of Pediatrics, University of Utah, Salt Lake City, UT
    • ,
  • Sonja A. Rasmussen, MD, MS

      Affiliations

    • National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA
    • ,
  • Adolfo Correa, MD, MPH

      Affiliations

    • National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA
    • ,
  • Jan M. Friedman, MD, PhD

      Affiliations

    • Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada
    • ,
  • National Birth Defects Prevention Study

Received 9 October 2009; received in revised form 10 December 2009; accepted 8 February 2010. published online 26 April 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Cite this article as: Alwan S, Reefhuis J, Botto LD, et al. Maternal use of bupropion and risk for congenital heart defects. Am J Obstet Gynecol 2010;203:52.e1-6.

 The National Birth Defects Prevention Study is funded by the Centers for Disease Control and Prevention.

 The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

PII: S0002-9378(10)00220-6

doi:10.1016/j.ajog.2010.02.015

American Journal of Obstetrics & Gynecology
Volume 203, Issue 1 , Pages 52.e1-52.e6, July 2010

Article Tools